Antibiotic Trials For COPD May Hinge On Patient-Reported Outcomes, FDA Says

Outcomes that are clinically important to patients should be the focus of clinical trials for antibiotics to treat acute bacterial exacerbation of chronic bronchitis in patients with chronic obstructive pulmonary disease, FDA recommends in a 1draft guidance released Aug. 21

More from Archive

More from Pink Sheet